Cargando…
PRES-like leukoencephalopathy presenting with status epilepticus associated with Brentuximab Vedotin treatment
Posterior Reversible Encephalopathy Syndrome (PRES) is characterized by acute neurological symptoms with typical imaging features, primarily in the territories of the brain supplied by the posterior circulation, probably due to vasogenic edema. Both clinical and imaging features are generally revers...
Autores principales: | Orsini, Alessandro, Bernasconi, Sayla, Bianchi, Maria Cristina, Trivelli, Ilaria, Menconi, Maria Cristina, Nardi, Margherita, Santangelo, Andrea, Casazza, Gabriella, Carli, Niccolò, Esposito, Mariagrazia, Peroni, Diego, Striano, Pasquale, Foiadelli, Thomas, Bonuccelli, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179058/ https://www.ncbi.nlm.nih.gov/pubmed/35441608 http://dx.doi.org/10.23750/abm.v92iS4.12665 |
Ejemplares similares
-
Brentuximab Vedotin
Publicado: (2012) -
Brentuximab vedotin induced uveitis
por: Therssen, Stijn, et al.
Publicado: (2022) -
The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series
por: Santangelo, Andrea, et al.
Publicado: (2022) -
Brentuximab Vedotin in CD30+ Lymphomas
por: Perini, Guilherme Fleury, et al.
Publicado: (2013) -
Brentuximab vedotin: axonal microtubule's Apollyon
por: Mariotto, S, et al.
Publicado: (2015)